Development and In Vivo Floating Behavior of Verapamil HCl Intragastric Floating Tablets
AUTOR(ES)
Patel, Anand
FONTE
Springer US
RESUMO
A novel gastro retentive controlled release drug delivery system of verapamil HCl was formulated in an effort to increase the gastric retention time of the dosage form and to control drug release. Hydroxypropylmethylcellulose (HPMC), carbopol, and xanthan gum were incorporated for gel-forming properties. Buoyancy was achieved by adding an effervescent mixture of sodium bicarbonate and anhydrous citric acid. In vitro drug release studies were performed, and drug release kinetics was evaluated using the linear regression method. The optimized intragastric floating tablet composed of 3:2 of HPMC K4M to xanthan gum exhibited 95.39% drug release in 24 h in vitro, while the buoyancy lag time was 36.2 s, and the intragastric floating tablet remained buoyant for >24 h. Zero-order and non-Fickian release transport was confirmed as the drug release mechanism from the optimized formulation (F7). X-ray studies showed that total buoyancy time was able to delay the gastric emptying of verapamil HCl intragastric floating tablet in mongrel dogs for more than 4 h. Optimized intragastric floating tablet showed no significant change in physical appearance, drug content, total buoyancy time, or in vitro dissolution pattern after storage at 40°C/75% relative humidity for 3 months.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2663699Documentos Relacionados
- Formulation and evaluation of bi-layer floating tablets of ziprasidone HCl and trihexyphenidyl HCl
- Floating tablets of hydralazine hydrochloride: optimization and evaluation
- Formulation and evaluation of glipizide floating-bioadhesive tablets
- Intragastric floating drug delivery system of cefuroxime axetil: In vitro evaluation
- Formulation and development of floating capsules of celecoxib: In vitro and in vivo evaluation